- Citado por SciELO
- Citado por Google
- Similares en SciELO
- Similares en Google
versión On-line ISSN 0717-9707
J. Chil. Chem. Soc. v.54 n.4 Concepción dic. 2009
J. Chil. Chem. Soc., 54, Nº 4 (2009), págs. 477-481.
ANTIMICROBIAL AND ANTIOXIDANT COMPOUNDS FROM THE INFUSION AND METHANOLIC EXTRACT OF Baccharis incarum (WEDD.) PERKINS.
IRIS CATIANA ZAMPINIa, MARÍA INÉS ISLAa*, AND GUILLERMO SCHMEDA-HIRSCHMANNb
aInstituto de Química del Noroeste Argentino (INQUINOA). CONICET. Universidad Nacional de Tucumán, Tucumán, Argentina. e-mail: firstname.lastname@example.org
bLaboratorio de Química de Productos Naturales, Instituto de Química de Recursos Naturales, Universidad de Talca, Talca, Chile.
In the traditional medicine of the South American highlands, the infusion and decoction of aerial parts of "tola", Baccharis incarum (Wedd.) Perkins (Asteraceae) is orally taken as an antiseptic, antipyretic and digestive or externally applied to relieve pain and infammation.
A plant infusion and methanolic (MeOH) extract of the aerial parts were compared for main constituents by HPLC-MS as well as assessed for antimicrobial and free radical scavenging activities. Assay-guided fractionation of the polar extracts was carried out using the ABTS+ autographic as well as methicillin-resistant Staphylococcus aureus and Enterococcus faecalis bioautographic test. Seven compounds were isolated from the polar extracts and identifed as chlorogenic acid, 3',4',5,7-tetrahydroxyfavone; dicaffeoyl quinic acid; 3',4',5,7-tetrahydroxy-3,6-dimethoxyfavone; 3',4',5,7-tetrahydroxy-3,6,8-trimethoxy favone, 4',5,7-trihydroxy-3',3,6,8-tetramethoxyfavone and 4',5-dihydroxy-3',3,6,7,8-pentamethoxyfavone. The main constituents from the methanol extract and infusion were caffeic acid derivatives. This is the frst report on the constituents of B. incarum infusion and show clear differences with previous phytochemical studies on the same plant. All isolated compounds showed antioxidant activity with SC50 values of 1 to 10 µg/ml. The isolated favones were active against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis with MICs in the range 100 and >200 µg/ml.
Key words: Baccharis incarum, Asteraceae, infusion, HPLC-MS, polyphenols, antimicrobial activity, antioxidant.
The genus Baccharis, with approximately 500 species is one of largest genera of the family Asteraceae. Baccharis species are abundant in Argentina where 96 species have been described1,2. Baccharis incarum (Wedd.) Perkins (syn.: Baccharis tola Phil.) known under the popular names lejia, tola and baila buena is common in the arid Andean highlands at 3,800 m above sea level in Antofagasta de la Sierra, Catamarca, Argentina. The infusion and decoction of the aerial parts of B. incarum are used in traditional medicine as an antiseptic and antipyretic, gastroprotective, digestive, anti-infammatory and to relieve muscle and bone pain. The leaves and stems are macerated in ethanol for seven days and the solution is rubbed to relieve rheumatism and infammation. Plant resin poultices are used in bruises and wounds and to consolidate luxations and broken bones 3-5. The plant resin has a sweet taste and the bumps in the branches (gills, sometimes called fruit) serve as a substitute for lemon6. B. incarum grow under conditions of high ultraviolet light, low temperature, high salinity and low atmospheric pressure.
Previous phytochemical studies on the leaves and top parts (aerial parts) of B. incarum described the isolation of diterpenes and favonoids7-9. In a screening of medicinal plants from the San Juan Province, Argentine, the antimicrobial effect of B. incarum extract on Gram positive and Gram negative bacteria by agar well diffusion method was reported10. The xanthine oxidase and antioxidant effect of its ethanolic extracts was described by Zampini et al. (2008)11. The aim of this work was to assess the antimicrobial activity against multi-resistant clinical isolates and free radical scavenging activity of aqueous and methanolic extracts of aerial parts of B. incarum and to identify the main constituents of the traditional crude drug preparation.
Nuclear magnetic resonance (NMR) spectra were obtained using a Bruker spectrometer, operating at 400 MHz for 1H and 100 MHz for 13C. Methanol (CD3OD) and/or chloroform (CDCl3) were used as solvents. The UV spectra were obtained using a Heλios α V-3.06 UV-VIS spectrophotometer. MeOH was used as solvent. HPLC-DAD was used for the identifcation and quantifcation of the main compounds in the crude extracts, fractions and as purity criteria of the isolated compounds before NMR measurements and assays.
The determination of phenolics in the samples was carried out as described in previous reports12,13. HPLC analysis was performed using HPLC-DAD Merck-Hitachi (LaChrom, USA) equipment consisting of a L-7100 pump, a L-7455 UV diode array detector and D-7000 chromato-integrator. A C18-RP column (Phenomenex, Torrence, CA 5 µm 250 mm x 4.60 mm. i.d.) was used. The compounds were monitored at 254 nm and the absorbance was measured between 200 and 400 nm. Gradient elution was carried out with water-0.1 % formic acid (solvent A) and methanol (solvent B) at a constant fow of 1 ml/ min. The solvent composition was as follows. Initial: 10% B, 90 % A, changing to 20% B at 10 min and to 75% B at 45 min, 5 minutes before starting to the initial conditions. Total running time: 50 min.
Mass spectra were measured with Agilent 1100LC equipment connected to an Esquire 4000 LC/MS (Bruker Daltoniks, Germany) system. Extracts and fractions were dissolved in MeOH:formic acid (99:1) (3 mg/ml) for the determinations. Full scan mass spectra were determined between m/z 150 and 2000 u in negative mode. Nitrogen at 27.5 psi, 350 ºC and a fow of 8 l/min was used as nebulization gas. Measurement conditions in negative ion mode were as follows: electrospray needle, 4000 v; end plate offset, -500 v; skimmer 1, -56.0 v; skimmer 2, -6.0 v; capillary outlet offset, -84.6 v.
Extract fngerprints and compound identifcation by HPLC-MS was carried out at a constant fow of 0.5 ml/min. The solvent composition was as follows. Initial: 10% B, 90 % A, changing to 20% B at 20 min and to 75% B at 90 min, 10 minutes before starting to the initial conditions. Total running time: 100 min.
Plant material and extraction B. incarum (Wedd.) Perkins (synonym: Baccharis tola Phil.) was collected in November 2007 in Antofagasta de la Sierra, Catamarca, Argentina at 3,800 m over sea level. The samples were dried in a dark place at room temperature. The parts used were leaves and stems. Voucher specimens were deposited in the Herbarium of "Fundación Miguel Lillo" San Miguel de Tucumán, Tucumán, Argentina and identifed by Lic. Soledad Cuello, Fundación Miguel Lillo (Voucher Number 607934 LIL).
The infusion was prepared by placing 200 g of air-dried and ground plant material in some 1l of hot water during 20 minutes. The aqueous extract was liophilized to afford 12 g of solubles (6 % w/w yield). The air-dried and ground plant material (1Kg) was extracted by maceration in methanol (1g/5ml) at room temperature during fve days. The methanolic extract (ME) was concentrated at reduced pressure to yield 264 g of solubles (26.4% w/w yield).
Compound isolation The methanolic extract was resuspended in water (0.5 l) and partitioned with dichloromethane (DCM, 1 l) to afford a DCM-soluble fraction (190 g), an aqueous phase (61.2 g) and a precipitate (PPT, 4 g) in the DCM-water interphase. The aqueous phase and the methanol-soluble precipitate presented similar TLC and HPLC-DAD patterns. The PPT (4 g) was dissolved in MeOH and permeated in a Sephadex LH-20 column (column length 60 cm, internal diameter 4.5 cm) using methanol as mobile phase. Some 38 fractions of 50 ml each were collected and pooled according to the TLC analysis (Kieselgel G60 F254 0.2 mm, Merck; mobile phase: ethyl acetate:chloroform 2:1 v/v). The plates were developed with a 0.2% diphenylboric acid ethanolamide complex methanolic solution and the compounds were visualized under UV light at 254 nm and 365 nm14. Bioautographic assays were performed to detect antimicrobial compounds. Fractions FR-IV (538 mg) and FR-V (423 mg), active towards Staphylococcus aureus, were further purifed by permeation on Sephadex LH-20 using methanol as the mobile phase. After TLC comparison, fractions with similar patterns obtained from FR-IV and FR-V were pooled in 7 bioactive groups. The bioactive pool FR2 (168 mg) was submitted to highspeed countercurrent chromatography (HSCCC). The HSCCC instrument (P. C. Inc., Potomac, MD) was equipped with a multilayer coil of 1.68 mm i.d. polytetrafuoroethylene (PTFE) tubing with a total capacity of 180 ml. The revolution radius, or the distance between the holder axis and the central axis of the centrifuge (R), was 10.5 cm, and the β value was 0.76 β = r/R, where r is the distance from the coil to the holder shaft. The speed varied between 0 and 1,200 rpm. The fow rate was controlled with a DC Analytic Gearmotor (Bodine Electric Company, Chicago, IL). The solvent system used was n-hexane:ethyl acetate: methanol: water 1:1.25:1:1.25; v/v/v/v. This system provided an ideal range of the partition coeffcient (K) for the applied sample and a desirable settling time (28 s); 66% of the stationary phase was retained in the coil. First, the coiled column was entirely flled with the stationary phase (upper phase, 320 ml). Then, the apparatus was rotated forward at 800 rpm, while the mobile phase (lower phase) was pumped into the column in a head to tail direction at a fow rate of 3.0 ml/min. After the mobile phase front emerged and the hydrodynamic equilibrium was established in the column, about 8 ml of fltered sample solution (dissolved in 4 ml of upper phase and 4 ml of lower phase) was injected through the injection module. The column effuent was continuously monitored by TLC on silica gel. The mobile phase was EtOAc:chloroform 2:1, v/v. The isolation of bioactive compounds is summarized in Fig 1.
The microorganisms used were clinical samples from Staphylococcus aureus (23 isolates) and Enterococcus faecalis (3 isolates), obtained from skin and soft tissue infections of patients of Hospital Nicolás Avellaneda, San Miguel de Tucumán, Tucumán, Argentina. The isolates included: MRSA (methicillin-resistant S. aureus), MSSA (methicillin-sensitive S. aureus), MRCNS (methicillin-resistant coagulase-negative staphylococci), MSCNS (methicillin-sensitive coagulase-negative staphylococci). A reference S. aureus strain (ATCC 29213) and E. faecalis (ATCC 29212) were included in the study. The strains were identifcated by biochemical profles15. All organisms were maintained and the inocula were prepared according to 16. The number of cells in CAMHB (cation-adjusted Müller Hinton broth) was estimated using a serial dilution technique for each assay17. The standard antibiotics: methicillin, vancomycin, oxaciline, gentamicin, ampicillin and streptomycin were used as reference compounds.
Minimal inhibitory concentration (MIC)
MIC values of extract and isolated compounds were determined by bioautographic assay in dot blot and by agar dilution methods17.
Agar macrodilution method
Serial dilutions (fnal volume 0.5 ml) of samples were prepared. Then, 4.5 ml of Müller-Hinton agar (MHA) were added. Plates were inoculated with 2 µl of each bacterial cell suspension (5x104 CFU) and aerobically incubated for 18 h at 35° C. A growth control of each tested strain was included. MIC100 was defned as the lowest concentration of soluble principle or antibiotics at which no colony was observed after incubation.
Plates of silica gel 60 F-254 (0.2 mm, Merck) were seeded in dot blot by duplicate with different fractions or compounds obtained in the purifcation process. One set of the plates were developed with ethyl acetate:chloroform (2:1, v/v), air-dried and the corresponding duplicate remained in dot blot. Bioautographic assay was performed using 2 ml of soft medium (BHI with 0.6% agar) containing 105 CFU of methicillin-resistant S. aureus (F7) according to16. The growth inhibition areas, yellow coloured, were compared with the Rf of the related spots on the TLC plate revealed with NP.
Total antioxidant capacity assay
Antioxidant capacity assay was carried out by the improved ABTS+ method as described by 18. ABTS+ radical cation was generated by reacting 7 mM ABTS and 2.45 mM potassium persulfate. The antioxidant capacity of the compounds was expressed as SC50 (scavenging concentration). All the measurements were conducted in triplicate and results were averaged.
ABTS + autography
For rapid visualization of free radical scavengers/antioxidants, the compounds were applied on silica gel TLC plates as described in Bioautographic assays. The plates were dried overnight and covered with 3 ml of agar 0.9 % containing 1 ml ABTS+. Plates were incubated at room temperature during 1 minute in the dark. Active samples appeared as light spots against a green-blue background. The antioxidant areas were compared with the Rf of the related spots on the TLC plate revealed with NP 11.
RESULTS AND DISCUSSION
From the aerial parts of B. incarum infusion and methanolic extract, several constituents were isolated and/or identifed by HPLC-MS and/ or spectroscopic methods. A representative HPLC trace of the B. incarum infusion and the identifcation of the main constituents of the water-soluble portion of the MeOH plant extract by HPLC-DAD, LC-MS and LCMS/MS data are presented in Fig. 2 and Table 1, respectively. According to the HPLC pattern, the main constituents of the plant infusion were chlorogenic acid and dicaffeoylquinic acid.
From the most polar part of the methanolic extract (water-soluble and precipitate), two caffeic acid derivatives and fve favonoids were obtained through assay-guided isolation and identifed by spectroscopic and spectrometric means. The fractionation schema is shown in Fig. 1. The 1H NMR, MS and UV of the compounds 1 (3', 4',5,7-tetrahydroxyfavone, luteolin), 2 (3',4',5,7-tetrahydroxy-3,6-dimethoxyfavone), 3 (3',4',5,7-tetrahydroxy-3,6,8-trimethoxyfavone), 4 (4',5,7-trihydroxy-3',3,6,8-tetramethoxy favone) and 5 (4',5 dihydroxy-3',3,6,7,8-pentamethoxyfavone) is in agreement with reported data19,20 while chlorogenic and dicaffeoylquinic acid were identifed by MS-MS, UV spectra and co-chromatography with a standard (chlorogenic acid)21,22. The structure of the favonoids 1-5 is presented in Fig. 3.
The crude methanolic extract was assessed for antimicrobial effect towards several strains of S. aureus and E. faecalis. The results are summarized in Table 2. The extract presented a relevant activity against both microorganisms, with some selectivity and MICs in the range 40-80 µg/ml. All isolated favonoids showed moderate to weak activity with MIC values around 100 and >200 µg/ml for S. aureus and E. faecalis (Table 3). In bioautographic assays, the quantities of isolated favonoids necessary to inhibit the growth of all strains were 5 µg until 20 µg (Table 3). The results suggest that the antimicrobial effect of the crude drug could be due to the isolated favonoids and other compounds not identifed in this study. The observed activity is in agreement with a previous study on a B. incarum sample collected at the Provincia de San Juan in Argentina. The antimicrobial methodology used, however, was agar diffusion and the ethanolic extract presented activity against both Gram positive and Gram negative organisms 10. These is the frst reports of antibacterial activity of B. incarum on MRSA, MSSA, MRCNS, MSCNS and E. faecalis antibiotic resistant obtained from skin and soft tissue infections of local hospital patients in comparison with American Type Culture Collection (ATCC) strains.
The free radical scavenging activity was determined for Baccharis extract and isolated compounds as well as for the synthetic and natural antioxidant (BHT, quercetin). The SC50 values were 4 μg/ml and 1-10 μg/ml for the total extract and the isolated compounds, respectively (Table 3). The investigation of the water infusion and water-soluble portion of the methanol extract of B. incarum allowed the identifcation of caffeic acid derivatives, including chlorogenic acid and dicaffeoylquinic acids as well as favonoids. The diterpenes previously described in B. incarum were not detected in the water infusion, what is not surprising due to the low polarity of those compounds 8,9. Chlorogenic acid and dicaffeoylquinic acids are know by its antioxidant effect23-25, antimicrobial26, antimutagenic27,28 activities. Five favones (Fig. 3) were isolated and identifed in the present report. Luteolin (compound 1) has been found to possess antiradical/antioxidative activity, especially when studied in cell-free systems29, as a glycolytic inhibitor might be a new adjuvant agent for chemotherapy 30, possess antiinfammatory31, antiespasmodic32 and antimicrobial activity33. Axilarin (compound 2) was reported in Artemisia copa and show antiinfammatory and antioxidant effect as well as inhibition on aldolase activity34-36. The compounds 3 and 4 have been previously found in other plant species 37,38 but its biological activity was not reported. The compound 5 (3-methoxycalipterin) was previously isolated from a Chilean collection of B. incarum7. In a study on the free radical scavenging effect of B. grisebachii 38, a strong free radical/antioxidant effect was observed for several favonoids of this plant. The favonoids from both Baccharis species present a similar substitution pattern with predominance of methoxylated derivatives, consistent with the chemistry of this plant group38,39.
In this work we report for the frst time the occurrence of further trihydroxylated and tetrahydroxylated favones in B. incarum as well as caffeoylquinic acid derivatives in the crude drug infusion and methanol extracts. The presence of these compounds can explain at least in part the antioxidant effect of the methanol extract and water infusion of the plant. The study of the water infusion allowed the identifcation of constituents very different from those previously reported from organic solvents extracts, clearly showing the need to follow the traditional recipes when performing studies on traditional uses of medicinal plants.
We thank fnancial support from the Programa de Investigación en Productos Bioactivos, Universidad de Talca and Consejo de Investigación de la Universidad Nacional de Tucumán (CIUNT), Argentina, Agencia Nacional de Promoción Científca y Técnica (ANPCyT) and the Consejo Nacional de Investigaciones Científcas y Técnicas (CONICET), Argentina.
1.- D. A. Giuliano, Darwiniana 39, 131, (2001). [ Links ]
2.- L. G. Verdi, I. M. C.Brighente, M. G. Pizzolatti, Quím. Nova 28, 85, (2005). [ Links ]
3.- M. Castro, C. Villagrán, M. Arroyo, In: El Hombre y los Ecosistemas de Montañas Veloso, A. & Bustos, E. eds. 1982; pp. 133-203. [ Links ]
4.- G. Wickens, Opera Bot. 121, 291, (1993). [ Links ]
5.- M. J. Abad, P. Bermejo, Arkivoc 7, 76, (2007). [ Links ]
6.- C. Aldunate, J. Armesto, V. Castro, C. Villagrán, Boletín del Museo Nacional de Historia Natural de Chile 38, 183 (1981). [ Links ]
7.- F. A. Faini, M. Castillo, M. R. Torres, J. Nat. Prod. 45, 501, (1982). [ Links ]
8.- A. Givovich, A. San-Martín, M. Castillo, Phytochem. 25, 2829, (1986). [ Links ]
9.- A. San Martín, A. Givovich, M. Castillo, Phytochem. 25, 264, (1986). [ Links ]
10.- G. E. Feresin, A. A. Tapia, D. A. Bustos, Fitoterapia 71, 429, (2000). [ Links ]
11.- I. C Zampini, J. Meson Gana, R. M. Ordoñez, J. E. Sayago, M. I. Nieva Moreno, M. I. Isla, Recent Progress in Medicinal Plants 21, 95, (2008). [ Links ]
12.- M. J. Simirgiotis, C. Theoduloz, P. D. S.Caligari, G. Schmeda-Hirschmann, Food Chem. 113, 377, (2009). [ Links ]
13.- E. Viveros-Valdez, C. Rivas-Morales, P. Carranza-Rosales, S. Mendoza, G. Schmeda-Hirschmann, Z. Naturforsch. 63c, 341, (2008). [ Links ]
14.- H. Wagner, S. Bladt, E. M. Zgainski, Plant drug analysis. A thin layer chromatography atlas. Springer-Verlag, Berlin & Heidelberg, 1984. [ Links ]
15.- P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, R. H. Yolke, Manual of Clinical Microbiology, Vol. 6. ASM, Washington, DC. 1999. [ Links ]
16.- I.C.Zampini, M.A. Vattuone, M.I.Isla, J. Ethnopharmacol. 102, 450, (2005). [ Links ]
17.- Clinical and Laboratory Standards Institute, Performance standards for Antimicrobial susceptibility testing; Seventeenth Informational Supplement M100-S17 Wayne, USA. 2006. [ Links ]
18.- R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M, Yang, C. Rice-Evans, Free Rad. Biol. Med. 26, 1231 (1999). [ Links ]
19.- T. J. Mabry, K. R. Markham, M. B. Thomas, The systematic identifcation of favonoids. Springer-Verlag, New York, U.S.A. 1970. [ Links ]
20.- P. K. Agrawal, Carbon - 13 NMR of Flavonoids. Studies in Organic Chemistry 39. Elsevier, Amsterdam, pp. 154,1989. [ Links ]
21.- H. Wang, M. Nair, G. M. Strasburg,, A. M. Booren, J. I. Gray, J. Agric. Food Chem. 47, 840, (1999). [ Links ]
22.- M. Sefkow, A. Kelling, U. Schilde, Eur. J. Org. Chem. 2735, (2001). [ Links ]
23.- C. A. Rice-Evans, N. J. Miller, G. Paganga, Free Rad. Biol. Med. 20, 933, (1996). [ Links ]
24.- O. Chun, D. Kim, H. Moon, H. Kang, C. Lee, J. Agric. Food Chem. 51, 7240, (2003). [ Links ]
25.- Z. Xiang, X. Ning, LWT-Food Sci. Technol. 41, 1189, (2008). [ Links ]
26.- H. Zhu, H. Zhang, R. Lo, J. Agric. Food Chem. 52, 7272, (2004). [ Links ]
27.- A. Francis, T. Shetty, R. Bhattacharya, Cancer Lett. 45, 177, (1989). [ Links ]
28.- T. Wang, X. Jiang, L. Yang, S. Wu, J. Chromatogr. A 1180, 53, (2008). [ Links ]
29.- M. Rüweler, A. Anker, M. Gülden, E. Maser, H. Seibert, Toxicol. in vitro 22, 1377, (2008). [ Links ]
30.- G. J. Du, Z. H. Song, H. H. Lin, X. F. Han, S. Zhang, Y. M.Yang, Biochem. Biophys Res. Commun. 372, 497, (2008). [ Links ]
31.- C. Chen, W. Peng, K. Tsai, S. Hsu, Life Sci. 81, 1602 (2007). [ Links ]
32.- H. Fleer, E. J. Verspohl, Phytomedicine 14, 409, (2007). [ Links ]
33.- Y. Sato, S. Suzaki, T. Nishikawa, M. Kihara, H. Shibata, T. Higuti, J. Ethnopharmacol. 72, 483 (2000). [ Links ]
34.- J. Okuda, I. Miwa, K. Inagaki, T. Horie, M. Nakayama, Biochem. Pharmacol. 31, 3807, (1982). [ Links ]
35.- S. Kim, M. Jung Park, M. Lee, S. Chung, E. Park, J. Kim, S. Kim, T. Oh, G. Markelonis, J. Kim, Free Rad. Biol. Med. 32, 596, (2002). [ Links ]
36.- V. Moscatelli, O. Hnatyszyn, C. Acevedo, J. Megias, M. J. Alcaraz, G. Ferraro, Planta Med. 72, 72, (2006). [ Links ]
37.- V. S. Martino, G. E. Ferraro, J. D. Coussio, Phytochem. 15, 1086, (1976). [ Links ]
38.- Dictionary of Natural Products on CDROM, Version 17:2, CRC Press, Taylor & Francis (2008). [ Links ]
39.- A.Tapia, J. Rodriguez, C. Theoduloz, S. Lopez, G. E. Feresin, G. Schmeda-Hirschmann, J. Ethnopharmacol. 95, 155 (2004). [ Links ]
(Received: April 29, 2009 - Accepted: September 9, 2009).